1 Recommendations

1 Recommendations

1.1 SeHCAT (tauroselcholic [75selenium] acid) is a potentially clinically important test for diagnosing bile acid malabsorption, which may be currently underdiagnosed. There is insufficient evidence to determine whether SeHCAT is a cost-effective option for diagnosing bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) and people with Crohn's disease without ileal resection. Therefore, for people with these conditions, SeHCAT is recommended for use in research to collect evidence about its clinical benefits and risks and the acceptability associated with diagnosing and treating bile acid malabsorption.

  • National Institute for Health and Care Excellence (NICE)